Vikram Verghese Sells 668 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ:HTFL) CFO Vikram Verghese sold 668 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $50.01, for a total transaction of $33,406.68. Following the sale, the chief financial officer directly owned 179,528 shares of the company’s stock, valued at $8,978,195.28. This trade represents a 0.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The shares were sold at an average price of $50.24, for a total value of $230,752.32.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The stock was sold at an average price of $50.06, for a total value of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The stock was sold at an average price of $50.03, for a total value of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total value of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The shares were sold at an average price of $50.60, for a total value of $297,325.60.

Heartflow Stock Performance

NASDAQ HTFL opened at $48.30 on Thursday. Heartflow, Inc. has a one year low of $20.13 and a one year high of $51.78. The stock has a 50-day moving average of $36.83 and a 200 day moving average of $31.38. The company has a market capitalization of $4.20 billion and a price-to-earnings ratio of -26.39.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million for the quarter. The business’s quarterly revenue was up 47.7% on a year-over-year basis. On average, equities analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Heartflow News Summary

Here are the key news stories impacting Heartflow this week:

• Positive Sentiment: Heartflow’s latest quarterly results remain a fundamental positive: revenue increased 47.7% year over year to $64.08 million, while the $0.07-per-share loss was substantially better than the $0.22 loss analysts expected. Heartflow earnings information
• Positive Sentiment: Analyst sentiment is still broadly favorable, with a consensus “Moderate Buy” rating. UBS initiated coverage with a $55 price target, although the broader average target of $44.88 is below recent trading levels.
• Neutral Sentiment: Institutional interest has provided some support, including Squarepoint Ops increasing its position by 72% and several funds initiating new stakes during the second quarter.
• Negative Sentiment: CFO Vikram Verghese sold 34,975 shares for approximately $1.75 million between September 11 and September 15 at prices near $50. He still directly owns 179,528 shares, but the repeated sales reduce insider ownership and may concern momentum-focused investors. The transactions were conducted under a pre-arranged trading plan. CFO SEC filing
• Negative Sentiment: CEO John C.M. Farquhar sold 38,900 shares for roughly $1.82 million in transactions dated September 10–11. The sales occurred as Heartflow traded near its 52-week high, reinforcing concerns that executives are taking profits and likely contributing to the stock’s recent decline. Heartflow CEO share sale
• Negative Sentiment: Heartflow remains unprofitable, with a negative net margin and analysts expecting a full-year loss of approximately $0.75 per share. Its valuation and sharp rise above the 50-day and 200-day moving averages could increase sensitivity to profit-taking.

Analyst Ratings Changes

HTFL has been the subject of a number of research analyst reports. Stifel Nicolaus lifted their target price on shares of Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. Canaccord Genuity Group increased their price target on Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a report on Friday, August 14th. UBS Group initiated coverage on Heartflow in a report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 price objective for the company. Morgan Stanley upped their price objective on Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research report on Friday, August 14th. Finally, JPMorgan Chase & Co. increased their target price on Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $44.88.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. XXEC Inc. bought a new stake in shares of Heartflow during the 2nd quarter valued at $2,524,764,000. BlackRock Inc. bought a new position in Heartflow in the 2nd quarter worth $152,502,000. Bamco Inc. NY purchased a new position in Heartflow during the second quarter valued at $94,625,000. Jupiter Topco LLC purchased a new position in Heartflow during the second quarter valued at $70,983,000. Finally, Janus Henderson Group PLC grew its holdings in Heartflow by 152.0% during the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after purchasing an additional 1,315,416 shares during the period.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).